MINNEWASKA AREA SCHOOLS STUDENT REGISTRATION/INFORMATION FORM District # 2149 409 4th St. S.E. School: Minnewaska Area Elementary Medical information: Student’s Legal Last Name Student’s Legal First Name: Non-aspirin (acetaminophen or Tylenol) will be provided when necessary ONLY in the case of low-grade fever. I DO give permission for the school nurse/staff to give my student an initial dose of non-aspirin (Tylenol) in the appropriate Middle Name Nick Name
dosage if needed for low-grade fever in accordance with a standing order of the school’s consulting physician.
I DO NOT give permission for my student to have non-aspirin. Birthdate BC Grade: Parent signature________________________________________________________Date______________________ Male Female Registration is for: 2. Ethnicity 5. If your child has an active IEP? Please identify student’s primary disability:
If any medication (prescription or over-the-counter) is to be given by school staff on a regular schedule, please contact the School
Is this student a new or returning
Developmental Cognitive Disabilities (mild)
Please consult the student handbook for the complete medication policy adopted by the Board of Education.
student to 2149
Developmental Cognitive Disabilities (Severe) **Is your student taking any medication on a regular basis at ______home_____school?
3. Student has been identified as or is receiving services for:
Name of medication/dosage__________________________________________________________________
Does Students have any Allergies? Has/Is student being treated for any of the following Physical Health concerns?
Reaction kit at school? Other/Comments:
4. Will student use busing? School most recently attended by student (Name, District #, city, Dates of Attendance Primary/Secondary Language Information Which Language did your child learn first? English Other (specify):_____________________________
Which Language is most often spoken in your home? English Other (specify):_____________________________
Which Language does your child usually speak?
FAMILY INFORMATION *
English Other (specify):_____________________________
Parent/Guardian #1 is the primary contact for district announcements and mailings.
Street Address Mailing address (if different than street address) City, State, Zip Home Phone Student Lives with: Student is resident School Reach
Mother Father Both of District 2149
Check all boxes you want to receive School Reach instant
Resident Parent/Guardian #1 First Name Cell # School Reach Relationship to Student (mother, father, grandparent etc.) Status of Parents: Last Name School Reach Resident Parent/Guardian #1 First Name Cell# School Reach Relationship to Student (mother, father, grandparent etc.) Mailing address if different than Last Name street address: Email School Reach Add 2nd Household Mailing-Parent/Guardian #2 Mailing Parent/Guardian #2 Name: City, State, Zip School Reach Add ADifferent Mailing Address Mailing Parent/Guardian #2 Mailing Address: The Family Education Records and Privacy Act provides that educational records are made available to each parent of a student.
Name of persons to call in an emergency other than a person the student lives with and who can pick up the student if necessary:
I CERTIFY THAT THE INFORMATION I PROVIDED IS TRUE AND CORRECT: Other Household Members under SIGNATURE DATE school age
Census: Name Birthdate Census: Name Birthdate Emergency #3 Name
RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO NOTA: ESTE RCM FOI O ANEXADO Á DECISÃO DA COMISSÃO, RELATIVA Á SUBMISSÃO PARA ARBITRAGEM; O TEXTO VÁLIDO NA ALTURA. O TEXTO NÃO É REVISTO OU ACTUALIZADO PELA EMEA E POR ISSO NÃO REPRESENTA NECESSARIAMENTE O TEXTO ACTUAL. 1. DENOMINAÇÃO MEDICAMENTO < Renitec e denominações associadas (ver Anexo I)>, <dosagem>,
Step Therapy Requirements Effective 2/1/2014 Effective Date: 02/01/2014 STEP THERAPY GROUP DESCRIPTION ANTI-INFLAMMATORY AGENTS - GI DRUG NAME ASACOL HD | DIPENTUM STEP THERAPY CRITERIA PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. Physicians United Plan Step Therapy Requirements Effective Date: 02/01/2014 STEP THERAPY GROUP DESCRIPT